The Kennedy Center‘s head of artistic programming has resigned, less than two weeks since his hire was announced. Kevin Couch told The Washington Post and The New York Times that he had stepped down ...
Edun emphasizes need for sustained, inclusive, job-rich growth Growth forecast at 4.68% for 2026, inflation to average 16.5% Reforms this year to focus on digital revenue collection and pro-poor tax ...
The United States will push forward with the next phase of its plan for peace in Gaza, moving toward "demilitarization, technocratic governance, and reconstruction," President Donald Trump's special ...
More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...
Getting your Trinity Audio player ready... A new phase of the $200 million Cherry Creek North redevelopment is underway, as construction begins on 250 Clayton, an eight-story, 175,000-square-foot ...
America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — one famous, one ignored — shift entirely the way we understand what ...
To fulfill the 2 Core Courses, take two Core Courses from two different Core Areas. CSE Core Courses are classified into six areas: Introduction to CSE, Computational Mathematics, High Performance ...
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized ...
U.S. President Donald Trump said on Sunday he is ready to move to a second phase of sanctioning Russia, the closest he has come to suggesting he is on the verge of ramping up sanctions against Moscow ...
HARLEM, Manhattan (WABC) -- The next phase of the Second Avenue subway is finally moving forward -- 50 years after the project came to a halt. The nearly $2 billion deal includes boring a new tunnel, ...
Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results